LIST OF TABLES

SUMMARY
Research studies have provided conflicting results regarding the possible link between flying duties and a higher incidence of testicular cancer. Most of these studies have looked exclusively at pilots or civilian aircrew. No studies to our knowledge have looked at the incidence of testicular cancer in enlisted male aircrew. A retrospective cohort study was conducted using the Automated Central Tumor Registry and Air Force Personnel Center data to determine the incidence of testicular cancer in U.S. Air Force active duty (AFAD) enlisted male aircrew and nonaircrew from 1998 to 2008. There were 13 AFAD enlisted male aircrew and 187 AFAD enlisted male nonaircrew diagnosed with testicular cancer. The sample of AFAD enlisted male nonaircrew had an incidence rate of 7.8 per 100,000, and the sample of AFAD enlisted male aircrew had an incidence rate of 16.6 per 100,000. The odds ratio (2.12) suggested that AFAD enlisted male aircrew had twice the odds of getting testicular cancer than their nonaircrew counterparts. However, a two-tailed t-test on the annual incidence rates revealed that there was no statistical significance between the testicular cancer incidence rates of male aircrew versus male nonaircrew in the AFAD enlisted sample population between 1998 and 2008.
BACKGROUND
Literature Review
Testicular cancer is a rare condition that has an annual incidence of 5. The incidence of testicular cancer seems to be highest in white, tall, Western Europeans (Ref 7) .
Aircrew seem to be at lower risk for cancer overall (Ref 9). However, many studies have found an increased incidence of certain cancers in aircrew. For example, some studies have shown a significant increase in incidence in melanoma and nonmelanoma cancers . Testicular cancer is another cancer that has been associated with flying duties. The reasons cited for this possible increase in testicular cancer incidence in aircrew include exposure to higher . Whether this increase in radiation exposure is large enough to cause testicular cancer is unknown. Other possible explanations for an increased cancer incidence in aircrew are exposure to sun and exposure to aircraft-generated electromagnetic fields. Some studies have found an increased incidence in testicular cancer in aircrew, but due mostly to small numbers, the findings were not statistically significant (Ref 11, 15) . Other studies have failed to find an increased incidence at all (Ref 16) . In 2010, a systematic literature review revealed one study that showed a significant increase in testicular cancer incidence in aircrew and five that showed only a slight increase in incidence (Ref 17) . The aforementioned studies on testicular cancer in aircrew were conducted in the civilian aviation community, and most were conducted with European populations. One study, however, showed a significant increase in testicular cancer in AFAD male aviators when compared to AFAD male nonflying officers (Ref 18). U.S. military studies looking at testicular cancer incidence in aircrew are rare, and even less common are studies looking at this association with enlisted aircrew. The purpose of this study is to determine if AFAD enlisted male aircrew have a significantly higher incidence of testicular cancer than their nonaircrew counterparts.
Aerospace Medicine Significance
Most studies looking at the incidence of testicular cancer in the flying community have looked at either civilian aircrew (pilots and flight attendants) or pilots exclusively. Additionally, testicular cancer is more common in the higher socioeconomic population. Since Air Force officers have higher incomes than Air Force enlisted personnel, conducting a study that examines AFAD enlisted male airmen explores the possibility that social status may have more to do with the higher incidence of testicular cancer in pilots than does their flying duties. The findings of this study could have an impact on current USAF screening and preventive measures for testicular cancer, thus reducing the incidence, reducing mortality, and saving money in healthcare.
Hypothesis and Research Question
The research question is: "Is the incidence rate of testicular cancer in AFAD enlisted male aircrew significantly higher than in nonaircrew?" The hypothesis is that there is no significant difference in the incidence of testicular cancer between the AFAD enlisted male aircrew population and the AFAD enlisted male nonaircrew population.
METHODS
The study subjects were AFAD enlisted male aircrew and nonaircrew with a diagnosis of testicular cancer. This retrospective cohort study was conducted by the review of extant data and did not require the participation of human or animal subjects. The appropriate Institutional Review Board granted approval for this study. Because the incidence of testicular cancer has increased over the past four decades, inclusion into this study of testicular cancer cases diagnosed well over a decade ago might skew the results. To reduce the effect of this potential confounder, the study population was limited to cases diagnosed no earlier than 1998. The most recent tumor registry data available for this research study were from 2008. Therefore, the study period is between 1998 and 2008. Raw data were obtained from the following sources:
• Automated Central Tumor Registry (ACTUR)
., Redmond, WA) spreadsheet from ACTUR. Only malignant testicular cancer can be reported in ACTUR. Therefore, inclusion of a cancer case in ACTUR with the primary site of involvement being the testis made that case eligible to participate in this study. Histologic distinctions were not made beyond this definition. The resulting ACTUR data originally contained 4,203 cases of testicular cancer. However, 3,106 cases associated with a non-USAF service were removed, including those without a service designation. Of the remaining 1,097 cases, 397 cases of personnel with nonenlisted ranks were removed from the list. Of the remaining 700 cases, 219 duplicate entries were removed. Two cases were removed from the dataset because they contained conflicting information; one case had two different military services and one had an officer rank and an enlisted rank listed. Of the remaining 479 cases, 44 nonactive duty cases were removed. Of the remaining 435 cases, 232 pre-1998 cases were removed from the sample population. The sample population at this point consisted of 203 cases.
ACTUR does not consistently list job descriptions; therefore, AFPC/DSYD supplemented 200 of the 203 ACTUR cases with duty information. Three cases were eliminated from the sample population because AFPC could not find any information on them. For the other 200, Air Force Specialty Codes (AFSCs), Aviation Service Codes (ASCs), and total flying hours were supplied. The enlisted AFSC is a five-character alphanumeric code assigned to a unique job description of USAF enlisted personnel. The ASC is a two-character alphanumeric code that designates flying status. To determine if a member was "aircrew," the presence of any flying hours and/or an assigned ASC as proof of flying duties was used. If neither flying hours nor ASC were present, but a flying-related duty AFSC (denoted by the 1AXXX format) was present, the subject was designated as "aircrew." In one case, neither ASC/flying hours nor a flying-related AFSC was present, but the entry in ACTUR clearly stated "loadmaster," so the subject was included as aircrew. The final sample consisted of 13 aircrew and 187 nonaircrew (200 cases total).
To obtain testicular cancer incidence rates, the entire AFAD enlisted male population had to be quantified. This information was obtained from the IDEAS database, which is available to the public (Ref 20) . Using IDEAS, the number of enlisted male aircrew (1AXXX AFSCs) and nonaircrew enlisted personnel (all other AFSCs) for each year from 1998 to 2008 was determined. A filter was used to remove all female personnel data from the final figures. Enlisted personnel without a listed AFSC were not included in the AFAD enlisted population.
A two-by-two table was constructed with the exposure (flying duties) on the y-axis and the outcome (testicular cancer) on the x-axis. Population data were entered into this table and incidence rates were calculated for AFAD enlisted male aircrew and nonaircrew populations. Subsequently, the odds ratio (OR) was calculated. Using Microsoft Excel 2010 Analysis ToolPak (Microsoft Corp., Redmond, WA), a two-tailed t-test was performed to determine if the difference in incident rates was statistically significant.
RESULTS
There were 200 diagnoses of testicular cancer (n=200) in the AFAD enlisted male population from 1998 to 2008. The mean age was 29. The ages ranged from 18 to 51 (see Table 1 ). White race accounted for 86% (n=172) of the study subjects (see Table 2 ); male nonaircrew accounted for 93.5% (n=187) and aircrew accounted for 6.5% (n=13) of the study subjects; and germ cell tumors accounted for 97% (n=194) of the testicular cancer diagnoses, while 1% (n=2) were stromal tumors and 2% (n=4) were not specified. Of the germ cell tumors, seminomas accounted for 54% (n=105), nonseminomas accounted for 18% (n=35), mixed (without mention of the specific cell types) accounted for 25% (n=48), and tumors categorized under the general terms "germ cell tumors" or "germinomas" accounted for 3% (n=6). Of the 11 AFAD enlisted male aircrew, nine were white, one was "other," and one was "unknown." Three were loadmasters, two were cryptologic linguist analysts, two were airborne mission systems specialists, one was an in-flight refueler (boom operator), one was a visual information specialist, one was an aerospace medicine specialist, and two could not be determined with certainty but had a designated ASC and/or had flying hours listed. Table 3 shows the number of cases and incidence of testicular cancer by year for aircrew and nonaircrew. The "errors" row shows cases that did not have a listed AFSC and were, therefore, not included in the calculations to determine the AFAD enlisted population. Using the calculated incidence rates for each year, an OR of 2.12 was obtained (see Table 4 ). A confidence interval was not calculated for this OR because the calculations for the OR were based on values that were dependent of each other. Using a two-tailed t-test (see Table 5 ), it was determined that the incidence rates of AFAD enlisted male aircrew and those of nonaircrew were not statistically significant. A twotailed t-test was used because the incidence of testicular cancer could have been higher or lower than the incidence in nonaircrew. 
DISCUSSION
The incidence of testicular cancer from 1998 to 2008 in AFAD enlisted male aircrew is 16.6 per 100,000, while the incidence in their nonaircrew counterparts is 7.8 per 100,000. However, because of the highly varying incidence of testicular cancer in a year-by-year basis in the aircrew population (ranging from zero to 48.5 per 100,000), there is no significant difference.
This study has several limitations. First, the denominator used to calculate the incidence rate is based on the annual running total of enlisted personnel in the AFAD community. Therefore, many of the AFAD male enlisted personnel counted in one year were counted again in the following year(s). Therefore, these were not independent samples. Another limitation is that age, race, socioeconomic status, and flying hours are potential confounding factors that were not controlled for in this study. Because of the very low incidence of testicular cancer, controlling for age may be difficult unless grouped into age ranges. Controlling for race can be accomplished with the data provided by AFPC; however, it was beyond the scope of this study. AFAD enlisted males were not stratified by the number of flying hours because data on flight hours were frequently missing. Only 54% of the data provided by AFPC reported aircrew flying hours. Further studies should attempt to control for one or all of the above potentially confounding factors.
The study population consisted of 86% white AFAD enlisted male aircrew. The percentages were similarly proportioned in the aircrew (84.6% white) and nonaircrew (86% white) populations. This differs from the percentage of white individuals (69.1%) in the U.S. population in the year 2000 (Ref 21) . Therefore, white race is overrepresented in the study population. Care must be taken not to extrapolate the findings of this study to the U.S. population. Further studies in the general aviation community would expand our understanding of the incidence of testicular cancer in aircrew.
CONCLUSIONS
Within the ADAF enlisted population from 1998-2008, there was no significant difference in the incidence rate of testicular cancer between aircrew and nonaircrew. This finding differs from the findings of other published research studies that suggest a possible link exists between flying duties and testicular cancer. Further research studies are encouraged to investigate this finding and add to the body of knowledge of the risk of testicular cancer in aircrew.
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